Geode Capital Management LLC Lowers Stock Holdings in PharmaCyte Biotech, Inc. (NASDAQ:PMCB)

Geode Capital Management LLC reduced its stake in PharmaCyte Biotech, Inc. (NASDAQ:PMCB) by 4.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 168,200 shares of the company’s stock after selling 8,405 shares during the quarter. Geode Capital Management LLC’s holdings in PharmaCyte Biotech were worth $321,000 at the end of the most recent reporting period.

PharmaCyte Biotech Trading Up 0.0 %

Shares of PMCB stock opened at $1.52 on Tuesday. The business’s 50 day moving average is $1.68 and its two-hundred day moving average is $1.79. PharmaCyte Biotech, Inc. has a twelve month low of $1.39 and a twelve month high of $2.58. The company has a market capitalization of $10.59 million, a P/E ratio of 2.87 and a beta of -0.22.

PharmaCyte Biotech (NASDAQ:PMCB) last announced its earnings results on Friday, December 13th. The company reported ($0.29) earnings per share for the quarter.

About PharmaCyte Biotech

PharmaCyte Biotech, Inc, a biotechnology company, develops and commercializes cellular therapies for cancer in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer.